2VVW
Structure of Vaccinia virus protein A52
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | ESRF BEAMLINE ID14-4 |
Synchrotron site | ESRF |
Beamline | ID14-4 |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2007-08-27 |
Detector | ADSC CCD |
Spacegroup name | P 1 21 1 |
Unit cell lengths | 46.208, 59.144, 75.719 |
Unit cell angles | 90.00, 106.58, 90.00 |
Refinement procedure
Resolution | 33.770 - 1.900 |
R-factor | 0.179 |
Rwork | 0.177 |
R-free | 0.21500 |
Structure solution method | MAD |
Starting model (for MR) | NONE |
RMSD bond length | 0.010 |
RMSD bond angle | 1.107 |
Data reduction software | HKL-2000 |
Data scaling software | HKL-2000 |
Phasing software | autoSHARP |
Refinement software | REFMAC (5.2.0019) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 50.000 | 1.930 |
High resolution limit [Å] | 1.900 | 1.900 |
Rmerge | 0.080 | 0.710 |
Number of reflections | 30971 | |
<I/σ(I)> | 12.1 | 1.9 |
Completeness [%] | 99.9 | 99.7 |
Redundancy | 4.1 | 4.1 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, HANGING DROP | 294 | HANGING DROPS CONTAINING 1 UL PROTEIN (5.3 MG/ML IN 20 MM TRIS, 200 MM NACL, PH 7.5) AND 1 UL RESERVOIR SOLUTION (0.2 M TRISODIUM CITRATE, 18% (W/V) PEG 3350) WERE EQUILIBRATED AGAINST 500 UL RESERVOIRS AT 21 C. CRYSTALS WERE CRYOPROTECTED IN RESERVOIR SOLUTION SUPPLEMENTED WITH 20% (V/V) GLYCEROL. |